Prescient Therapeutics Raises $8m for cancer treatment therapies
Prescient Therapeutics (PTX) is looking to raise $8 million via a share purchase plan (SPP) to...
Prescient Therapeutics (PTX) has announced a new research program with the Peter MacCallum Cancer Centre to advance its next-generation CAR-T programs
CAR-T is...
